Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain

Figure 4

Functional recovery and mortality after focal cerebral ischemia. (a) Low-dose fimasartan improved functional recovery after transient focal ischemia compared to PBS-controls with MCAO. This improvement was prominent at 14 days after ischemia (; for 0.5 mg/kg and for control). (b) The mortality rate decreased significantly in the low-dose fimasartan group compared with PBS-controls with MCAO ( by log-rank test < 0.05; each).

(a)

(b)